Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
Puromycin Generation of KCNH2 heterozygous knockout induced pluripotent stem cell (iPSC... 2024 Stem Cell Res. Wang B. et al. DOI: 10.1016/j.scr.2024.103400
Plasmocin® - Mycoplasma Elimination Reagent N6-isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by ... 2024 FEBS Open Bio. Pagano C. et al. DOI: 10.1002/2211-5463.13766
Puromycin Molecular basis promoting centriole triplet microtubule assembly. 2024 Nat Commun. Takeda Y. et al. DOI: 10.1038/s41467-024-46454-x
Hygromycin B Gold Molecular basis promoting centriole triplet microtubule assembly. 2024 Nat Commun. Takeda Y. et al. DOI: 10.1038/s41467-024-46454-x
LFn-Needle Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... 2024 Life Sci Alliance Vande Walle L. et al. DOI: 10.26508/lsa.202402644
Nano-SiO2 Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... 2024 Life Sci Alliance Vande Walle L. et al. DOI: 10.26508/lsa.202402644
LPS-SM Ultrapure (LPS from S. minnesota R595) Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... 2024 Life Sci Alliance Vande Walle L. et al. DOI: 10.26508/lsa.202402644
Pam3CSK4 Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... 2024 Life Sci Alliance Vande Walle L. et al. DOI: 10.26508/lsa.202402644
R848 (Resiquimod) Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with hi... 2024 Life Sci Alliance Vande Walle L. et al. DOI: 10.26508/lsa.202402644
ATP Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect... 2024 Phytomedicine Ruan Y. et al. DOI: 10.1016/j.phymed.2024.155564
LPS-B5 (LPS from E. coli 055:B5) Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect... 2024 Phytomedicine Ruan Y. et al. DOI: 10.1016/j.phymed.2024.155564
Primocin® Accessible luminal interface of bovine rectal organoids generated from cryopr... 2024 PLoS One Kawasaki M. & Ambrosini Y.M. DOI: 10.1371/journal.pone.0301079
Primocin® Comparison of Minced Cartilage Implantation with Autologous Chondrocyte Trans... 2024 Cells Ossendorff R. et al. DOI: 10.3390/cells13060546
LPS-PG (Lipopolysaccharide from P. gingivalis) Proteomic analysis of P. gingivalis-Lipopolysaccharide induced neuroinflammat... 2024 Geroscience Verma A. et al. DOI: 10.1007/s11357-024-01117-z
Normocin™ - Antimicrobial Reagent Feedback activation of CD73-Adenosine axis attenuates the antitumor immunity ... 2024 BBRC Fu N. et al. DOI: 10.1016/j.bbrc.2024.149814
Blasticidin Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. 2024 PLoS One Bai M. et al. DOI: 10.1371/journal.pone.0299665
Zeocin® Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. 2024 PLoS One Bai M. et al. DOI: 10.1371/journal.pone.0299665
Hygromycin B Gold Targeted degradation of zDHHC-PATs decreases substrate S-palmitoylation. 2024 PLoS One Bai M. et al. DOI: 10.1371/journal.pone.0299665
QUANTI-Luc™: Luciferase Detection Reagent Galectin 7 leads to a relative reduction in CD4+ T cells, mediated by PD-1. 2024 Sci Rep. Wu G. et al. DOI: 10.1038/s41598-024-57162-3
pFUSE-hIgG1-Fc Galectin 7 leads to a relative reduction in CD4+ T cells, mediated by PD-1. 2024 Sci Rep. Wu G. et al. DOI: 10.1038/s41598-024-57162-3

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty